Meridian Bioscience Obtains FDA Clearance For Legionella Test - Quick Facts

Meridian Bioscience Sees Q1 Results Below Consensus; Reaffirms FY14 Outlook

Trade VIVO now with

2/27/2012 1:07 PM ET

Meridian Bioscience Inc. (VIVO: Quote) announced that it has received clearance from the U.S. Food and Drug Administration for TRU Legionella, a new rapid assay for detection of legionellosis.

TRU Legionella is a rapid lateral flow device that provides optimized detection of Legionella pneumophila serogroup that is most commonly associated with Legionnaire's disease. Suspected infection is characterized by non-specific upper respiratory symptoms.

Click here to receive FREE breaking news email alerts for Meridian Bioscience Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

<<Previous 42 Articles

Editors Pick

Sharply Falling Inflation Expectations Facilitate BoE To Hold Rates

Sharply reduced inflation expectations facilitates the Bank of England to keep interest rates down at 0.50 percent for some time to come, IHS Global Insight's Chief UK Economist Howard Archer said in a note.

Malaysia Airlines Flight Goes Missing

A Malaysia Airlines plane with 239 on board went missing above the South China Sea on Saturday. The MH370 Boeing 777-200ER flight from Kuala Lumpur to Beijing was carrying passengers of 14 countries, which includes two infants and 12 crew. While unofficial reports in the Vietnamese media said...

China February Exports Plunge; Import Growth Accelerates

Chinese exports declined unexpectedly, while growth in imports accelerated in February, taking the trade balance surprisingly to a negative zone. Exports declined sharply by 18.1 percent, reversing the 10.6 percent increase in January, data from the General Administration of Customs showed Saturday. The decline was in contrast to a 7.5 percent rise forecast by economists.